Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.14 -0.74 (-2.86%)
Official Closing Price Updated: 7:00 PM EDT, Aug 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
What's going on in today's session: S&P500 gap up and gap down stocks
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
Pfizer Beats Expectations In Q2 2025, Raises EPS Guidance
Pfizer's second-quarter 2025 results exceeded expectations with a 10% revenue growth and an adjusted EPS of $0.78. 
Via Talk Markets
Pfizer Cost-Cut Initiatives More Than Offset Tariffs Impact, Raises Outlook
Pfizer posts better-than-expected Q2 earnings and sales, raises 2025 EPS outlook, and outlines $7.7 billion in cost-saving initiatives through 2027. 
Via Benzinga
Dow Surges Over 100 Points; Pfizer Earnings Top Views
 
Via Benzinga
Topics Stocks
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Earnings Outlook For Pfizer
 
Via Benzinga
Pfizer Smashes Earnings Forecasts And Raises Outlook; Shares Jump
Shares advanced within striking distance of their 50-day line. 
Via Investor's Business Daily
Zoetis (NYSE:ZTS) Posts Better-Than-Expected Sales In Q2, Stock Soars
Animal health company Zoetis (NYSE:ZTS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue... 
Via StockStory
If You'd Invested $1,000 in PFE 5 Years Ago, Here's How Much You'd Have Today
It's been a roller-coaster ride for Pfizer's stock over the past half-decade. 
Via The Motley Fool
Topics Intellectual Property
Pfizer (NYSE:PFE) Reports Upbeat Q2
Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q2 CY2025, with sales up 10.3% year on year to $14.65 billion. The company expects the full year’s revenue to... 
Via StockStory
Dow Futures Rise As Investors Shift Focus To Earnings: PFE, PLTR, TSLA, BP, AMD Among Stocks To Watch
Via Stocktwits
Topics Stocks
Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance
From Pfizer Inc.
Via Business Wire
Stock Market Today: US Stock Futures Inch Higher, As Analysts Warn of Volatile August—AMD, Pfizer, Caterpillar In Focus
U.S. stock futures are inching higher on Tuesday, following a strong rally on Monday, with major benchmark indices in the green. 
Via Benzinga
3 Healthcare Stocks Paying the Highest Dividends of 2025
Income investors seeking juicy dividends should check out these healthcare stocks. 
Via The Motley Fool
Topics Intellectual Property
3 Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 6.72% -- That Make for No-Brainer Buys in August
Three time-tested companies with rock-solid payouts can pad investors' pocketbooks for a long time to come. 
Via The Motley Fool
Topics Energy Government World Trade
S&P 500 Snaps Four-Day Losing Streak: Investor Sentiment Improves, Fear Index In 'Greed' Zone
At a current reading of 56.5, the index remained in the "Greed" zone on Monday, versus a prior reading of 56.1. 
Via Benzinga
Topics Stocks
Caterpillar, Pfizer And 3 Stocks To Watch Heading Into Tuesday
US stock futures up, key stocks to watch: Caterpillar, Pfizer, Paymentus, Palantir, AMD. Check out premarket coverage. 
Via Benzinga
The Smartest Dividend Stocks to Buy With $10,000 Right Now
Thanks to some misguided short-term setbacks, investors can scoop up a trio of dividend-paying bargains here. 
Via The Motley Fool
Topics Earnings World Trade
Michael McTague: How can anyone afford breakthrough medicines?
The cost of high-end, breakthrough medications traumatizes patients and their families. According to USAfacts, “national spending on personal health care has 
Via Equities.com
BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth
BioNTech beat Q2 estimates with higher COVID vaccine revenue and reaffirmed 2025 guidance. 
Via Benzinga
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
Via Investor Brand Network
Topics Government
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
EQNX::TICKER_START (NASDAQ:SNGX),(NYSE:PFE),(NYSE:MRK),(NYSE:BMY),(NASDAQ:INSM) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Government
How To Earn $500 A Month From Pfizer Stock Ahead Of Q2 Earnings
Pfizer offers a semi-annual dividend amount of 43 cents per share. Here's how investors can pocket a regular $500 monthly. 
Via Benzinga
This Biotech Stock Could Soar on Upcoming Clinical Data
This weight loss drugmaker may be significantly undervalued right now. 
Via The Motley Fool
3 Top Dividend Stocks to Buy in August
These stocks are great ways for investors to generate passive income. 
Via The Motley Fool
Pfizer's Ascent Signals Broader Health Sector Resilience Amidst Innovation Wave
In a notable shift, shares of Pfizer (NYSE: PFE) have recently edged higher, reflecting a burgeoning strength within the broader health sector. This uptick signals a renewed investor confidence in the... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
From Apothecary to Global Powerhouse: The Enduring Legacy of Pfizer
Pfizer (NYSE: PFE), a name synonymous with pharmaceutical innovation and global health, stands as a testament to over 170 years of scientific endeavor and strategic evolution. What began as a modest... 
Via MarketMinute
Topics Economy
Pfizer (PFE) Reports Earnings Tomorrow: What To Expect
Global pharmaceutical company Pfizer (NYSE:PFE) will be announcing earnings results this Tuesday before market open. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
The 3 Things That Matter for Pfizer Now
The sell-off of this pharmaceutical giant might be overdone. 
Via The Motley Fool
3 High-Yielding Dividend Stocks That Are Trading Near Their 52-Week Lows
If you are looking for dividend stocks, a good place to start is with unloved stocks like these, with yields of up to 6.4%. 
Via The Motley Fool
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.